Literature DB >> 2169842

Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading.

D L Arnold1, E A Shoubridge, J G Villemure, W Feindel.   

Abstract

We have obtained localized, water-suppressed proton magnetic resonance spectra from eleven astrocytomas in vivo. Localized phosphorus spectra were also obtained from three of these tumors. All tumors were examined prior to surgery, radiotherapy or chemotherapy. Examinations were performed with a commercially available 1.5 Tesla combined imaging and spectroscopy system using a stimulated echo pulse sequence for protons and an ISIS pulse sequence for phosphorus. A relatively high lactate resonance intensity correlated with a more malignant histological tumor grade and more aggressive behaviour. The resonance intensity of N-acetylaspartate/creatine was decreased and choline/creatine was increased, but these did not reliably discriminate between tumor grades. Other unidentified resonances not present in spectra of normal brain were sometimes seen. Proton magnetic resonance spectroscopy provides a new method for determining the metabolic behaviour of astrocytomas that may be useful in the clinical assessment of patients with these tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169842     DOI: 10.1002/nbm.1940030407

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  16 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 2.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

3.  Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

Authors:  K B Quattrocchi; C H Miller; S Cush; S A Bernard; S T Dull; M Smith; S Gudeman; M A Varia
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy.

Authors:  Fumiyuki Yamasaki; Junko Takaba; Megu Ohtaki; Nobukazu Abe; Yoshinori Kajiwara; Taiichi Saito; Hiroyuki Yoshioka; Seiji Hama; Tomohide Akimitsu; Kazuhiko Sugiyama; Kazunori Arita; Kaoru Kurisu
Journal:  Neurosurg Rev       Date:  2005-08-18       Impact factor: 3.042

5.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.

Authors:  C Dowling; A W Bollen; S M Noworolski; M W McDermott; N M Barbaro; M R Day; R G Henry; S M Chang; W P Dillon; S J Nelson; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

6.  In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements.

Authors:  J M Star-Lack; E Adalsteinsson; M F Adam; D J Terris; H A Pinto; J M Brown; D M Spielman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 7.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

Review 8.  What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

Authors:  J Vion-Dury; D J Meyerhoff; P J Cozzone; M W Weiner
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

9.  Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy.

Authors:  M A Heesters; R L Kamman; E L Mooyaart; K G Go
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

10.  Creatine CEST MRI for Differentiating Gliomas with Different Degrees of Aggressiveness.

Authors:  Kejia Cai; Rong-Wen Tain; Xiaohong Joe Zhou; Frederick C Damen; Alessandro M Scotti; Hari Hariharan; Harish Poptani; Ravinder Reddy
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.